Donoghue Forlines LLC Gilead Sciences, Inc. Transaction History

Donoghue Forlines LLC

$342 Million
Q3 2024

A detailed history of Donoghue Forlines LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Donoghue Forlines LLC holds 26,430 shares of GILD stock, worth $2.48 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

26,430

Previous 20,073 31.67%

Holding current value

$2.48 Million

Previous $1.38 Million 60.86%

% of portfolio

0.65%

Previous 0.4%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $423,312 - $533,924	6,357 Added 31.67%	26,430 $2.22 Million
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $145,813 - $168,279	2,309 Added 13.0%	20,073 $1.38 Million
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $231,131 - $281,859	3,229 Added 22.22%	17,764 $1.3 Million
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $1.46 Million - $1.66 Million	-19,949 Reduced 57.85%	14,535 $1.18 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $454,804 - $496,201	6,151 Added 21.71%	34,484 $2.58 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $169,274 - $193,080	2,227 Added 8.53%	28,333 $2.18 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $421,726 - $480,476	-5,455 Reduced 17.28%	26,106 $2.17 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $1.06 Million - $1.52 Million	17,022 Added 117.08%	31,561 $2.71 Million
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $762,588 - $871,072	-12,808 Reduced 46.84%	14,539 $897,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $832,033 - $937,119	-14,415 Reduced 34.52%	27,347 $1.69 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $554,468 - $694,808	9,573 Added 29.74%	41,762 $2.48 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $145,655 - $165,321	-2,245 Reduced 6.52%	32,189 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1 Million - $1.08 Million	14,845 Added 75.78%	34,434 $2.41 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $17,009 - $18,585	268 Added 1.39%	19,589 $1.35 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1.13 Million - $1.29 Million	-18,853 Reduced 49.39%	19,321 $1.25 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $2.16 Million - $2.46 Million	38,174 New	38,174 $2.22 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $4.06 Million - $4.47 Million	-65,953 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$62.51 - $69.0 $1.92 Million - $2.12 Million	-30,722 Reduced 31.78%	65,953 $4.18 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $5.98 Million - $6.71 Million	96,675 New	96,675 $6.53 Million
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $11.1 Million - $14.5 Million	-183,324 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $3.05 Million - $3.38 Million	-42,799 Reduced 18.93%	183,324 $14.2 Million
Q2 2018 Jul 26, 2018	BUY	$64.88 - $75.68 $287,029 - $334,808	4,424 Added 2.0%	226,123 $16 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $1.09 Million - $1.33 Million	-15,000 Reduced 6.34%	221,699 $16.7 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $14.9 Million - $17.5 Million	209,486 Added 769.8%	236,699 $17 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.96 Million - $2.33 Million	27,213	27,213 $2.21 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account

Donoghue Forlines LLC Gilead Sciences, Inc. Transaction History